149 related articles for article (PubMed ID: 26146667)
1. Summaries for Patients. The Obesity Paradox in Type 2 Diabetes Mellitus.
Ann Intern Med; 2015 May; 162(9):I-26. PubMed ID: 26146667
[No Abstract] [Full Text] [Related]
2. The obesity paradox in type 2 diabetes mellitus: relationship of body mass index to prognosis: a cohort study.
Costanzo P; Cleland JG; Pellicori P; Clark AL; Hepburn D; Kilpatrick ES; Perrone-Filardi P; Zhang J; Atkin SL
Ann Intern Med; 2015 May; 162(9):610-8. PubMed ID: 25938991
[TBL] [Abstract][Full Text] [Related]
3. Overweight and obesity and weight change in middle aged men: impact on cardiovascular disease and diabetes.
Wannamethee SG; Shaper AG; Walker M
J Epidemiol Community Health; 2005 Feb; 59(2):134-9. PubMed ID: 15650145
[TBL] [Abstract][Full Text] [Related]
4. Summaries for patients. Is obesity harmful if metabolic factors are normal?
Ann Intern Med; 2013 Dec; 159(11):I-26. PubMed ID: 24297208
[No Abstract] [Full Text] [Related]
5. Prevalence of obesity in type 2 diabetes in secondary care: association with cardiovascular risk factors.
Daousi C; Casson IF; Gill GV; MacFarlane IA; Wilding JP; Pinkney JH
Postgrad Med J; 2006 Apr; 82(966):280-4. PubMed ID: 16597817
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of cardiovascular disease risk factors among UK commercial pilots.
Houston S; Mitchell S; Evans S
Eur J Cardiovasc Prev Rehabil; 2011 Jun; 18(3):510-7. PubMed ID: 21450633
[TBL] [Abstract][Full Text] [Related]
7. [Adiposity paradox in cardiovascular disease].
Holzgreve H
MMW Fortschr Med; 2014 May; 156(9):63-4. PubMed ID: 24908893
[No Abstract] [Full Text] [Related]
8. Risk of diabetes and cardiovascular disease: best to return back to the basics: comment on "Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus".
Deedwania PC
Arch Intern Med; 2010 Sep; 170(17):1575-7. PubMed ID: 20876409
[No Abstract] [Full Text] [Related]
9. Body Mass Index-Related Mortality in Patients with Type 2 Diabetes and Heterogeneity in Obesity Paradox Studies: A Dose-Response Meta-Analysis.
Kwon Y; Kim HJ; Park S; Park YG; Cho KH
PLoS One; 2017; 12(1):e0168247. PubMed ID: 28046128
[TBL] [Abstract][Full Text] [Related]
10. Obesity paradox: differential effects on cancer and noncancer mortality in patients with type 2 diabetes mellitus.
Tseng CH
Atherosclerosis; 2013 Jan; 226(1):186-92. PubMed ID: 23040832
[TBL] [Abstract][Full Text] [Related]
11. Body mass index in type 2 diabetes mellitus complications: hypertensive diabetics and diabetic nephropathy.
Idogun ES; Unuigbe EI; Famodu AA; Akinola OT
Niger Postgrad Med J; 2006 Mar; 13(1):17-20. PubMed ID: 16633373
[TBL] [Abstract][Full Text] [Related]
12. Body mass index and the risk of total and cardiovascular mortality among patients with type 2 diabetes: a large prospective study in Ukraine.
Khalangot M; Tronko M; Kravchenko V; Kulchinska J; Hu G
Heart; 2009 Mar; 95(6):454-60. PubMed ID: 18697804
[TBL] [Abstract][Full Text] [Related]
13. Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects.
James WP; Caterson ID; Coutinho W; Finer N; Van Gaal LF; Maggioni AP; Torp-Pedersen C; Sharma AM; Shepherd GM; Rode RA; Renz CL;
N Engl J Med; 2010 Sep; 363(10):905-17. PubMed ID: 20818901
[TBL] [Abstract][Full Text] [Related]
14. Obesity and the "obesity paradox" in cardiovascular diseases.
Lavie CJ; Milani RV; Ventura HO
Clin Pharmacol Ther; 2011 Jul; 90(1):23-5. PubMed ID: 21691270
[TBL] [Abstract][Full Text] [Related]
15. Obesity is associated with lower mortality risk in elderly diabetic subjects: the Casale Monferrato study.
Perotto M; Panero F; Gruden G; Fornengo P; Lorenzati B; Barutta F; Ghezzo G; Amione C; Cavallo-Perin P; Bruno G
Acta Diabetol; 2013 Aug; 50(4):563-8. PubMed ID: 22068621
[TBL] [Abstract][Full Text] [Related]
16. A low carbohydrate Mediterranean diet improves cardiovascular risk factors and diabetes control among overweight patients with type 2 diabetes mellitus: a 1-year prospective randomized intervention study.
Elhayany A; Lustman A; Abel R; Attal-Singer J; Vinker S
Diabetes Obes Metab; 2010 Mar; 12(3):204-9. PubMed ID: 20151996
[TBL] [Abstract][Full Text] [Related]
17. [Diabesity and cardiovascular diseases: Novel mediators and novel targets].
Stoclet JC
Ann Pharm Fr; 2013 Jan; 71(1):4-6. PubMed ID: 23348850
[No Abstract] [Full Text] [Related]
18. Framingham, SCORE, and DECODE risk equations do not provide reliable cardiovascular risk estimates in type 2 diabetes.
Coleman RL; Stevens RJ; Retnakaran R; Holman RR
Diabetes Care; 2007 May; 30(5):1292-3. PubMed ID: 17290036
[No Abstract] [Full Text] [Related]
19. The domino effect: obesity, type 2 diabetes and cardiovascular disease.
Green V
Br J Community Nurs; 2005 Aug; 10(8):358-61. PubMed ID: 16116394
[TBL] [Abstract][Full Text] [Related]
20. The obesity paradox.
Taylor J
Eur Heart J; 2011 Jul; 32(13):1575-6. PubMed ID: 21853557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
